Cell transplantation for retinal degeneration: Transition from rodent to nonhuman primate models

Trevor McGill, David Wilson, Jonathan Stoddard, Lauren M. Renner, Martha Neuringer

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Transplantation of potentially therapeutic cells into the subretinal space is a promising prospective therapy for the treatment of retinal degenerative diseases including age-related macular degeneration (AMD). In rodent models with photoreceptor degeneration, subretinal transplantation of cell suspensions has repeatedly been demonstrated to rescue behaviorally measured vision, maintain electrophysiological responses from the retina and the brain, and slow the degeneration of rod and cone photoreceptors for extended periods. These studies have led to the initiation of a number of FDA-approved clinical trials for application of cell-based therapy for AMD and other retinal degenerative diseases. However, translation from rodent models directly into human clinical trials skips an important intermediary preclinical step that is needed to address critical issues for intraocular cell transplantation. These include determination of the most appropriate and least problematic surgical approach, the application of treatment in an eye with similar size and structure including the presence of a macula, and a thorough understanding of the immunological considerations regarding graft survival and the consequences of grafted cell rejection. This chapter will review these and related issues and will document current efforts to address these concerns.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages641-647
Number of pages7
DOIs
StatePublished - Jan 1 2018

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1074
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Retinal Degeneration
Cell Transplantation
Primates
Rodentia
Retinal Diseases
Macular Degeneration
Grafts
Cones
Brain
Suspensions
Clinical Trials
Retinal Cone Photoreceptor Cells
Retinal Rod Photoreceptor Cells
Graft Survival
Therapeutics
Cell- and Tissue-Based Therapy
Retina
Transplantation

Keywords

  • Cell transplantation
  • Immune rejection
  • Nonhuman primate
  • Retinal pigment epithelial cells
  • Surgery

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

McGill, T., Wilson, D., Stoddard, J., Renner, L. M., & Neuringer, M. (2018). Cell transplantation for retinal degeneration: Transition from rodent to nonhuman primate models. In Advances in Experimental Medicine and Biology (pp. 641-647). (Advances in Experimental Medicine and Biology; Vol. 1074). Springer New York LLC. https://doi.org/10.1007/978-3-319-75402-4_78

Cell transplantation for retinal degeneration : Transition from rodent to nonhuman primate models. / McGill, Trevor; Wilson, David; Stoddard, Jonathan; Renner, Lauren M.; Neuringer, Martha.

Advances in Experimental Medicine and Biology. Springer New York LLC, 2018. p. 641-647 (Advances in Experimental Medicine and Biology; Vol. 1074).

Research output: Chapter in Book/Report/Conference proceedingChapter

McGill, T, Wilson, D, Stoddard, J, Renner, LM & Neuringer, M 2018, Cell transplantation for retinal degeneration: Transition from rodent to nonhuman primate models. in Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology, vol. 1074, Springer New York LLC, pp. 641-647. https://doi.org/10.1007/978-3-319-75402-4_78
McGill T, Wilson D, Stoddard J, Renner LM, Neuringer M. Cell transplantation for retinal degeneration: Transition from rodent to nonhuman primate models. In Advances in Experimental Medicine and Biology. Springer New York LLC. 2018. p. 641-647. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-3-319-75402-4_78
McGill, Trevor ; Wilson, David ; Stoddard, Jonathan ; Renner, Lauren M. ; Neuringer, Martha. / Cell transplantation for retinal degeneration : Transition from rodent to nonhuman primate models. Advances in Experimental Medicine and Biology. Springer New York LLC, 2018. pp. 641-647 (Advances in Experimental Medicine and Biology).
@inbook{c472713c7b0e448694a77fab82e83865,
title = "Cell transplantation for retinal degeneration: Transition from rodent to nonhuman primate models",
abstract = "Transplantation of potentially therapeutic cells into the subretinal space is a promising prospective therapy for the treatment of retinal degenerative diseases including age-related macular degeneration (AMD). In rodent models with photoreceptor degeneration, subretinal transplantation of cell suspensions has repeatedly been demonstrated to rescue behaviorally measured vision, maintain electrophysiological responses from the retina and the brain, and slow the degeneration of rod and cone photoreceptors for extended periods. These studies have led to the initiation of a number of FDA-approved clinical trials for application of cell-based therapy for AMD and other retinal degenerative diseases. However, translation from rodent models directly into human clinical trials skips an important intermediary preclinical step that is needed to address critical issues for intraocular cell transplantation. These include determination of the most appropriate and least problematic surgical approach, the application of treatment in an eye with similar size and structure including the presence of a macula, and a thorough understanding of the immunological considerations regarding graft survival and the consequences of grafted cell rejection. This chapter will review these and related issues and will document current efforts to address these concerns.",
keywords = "Cell transplantation, Immune rejection, Nonhuman primate, Retinal pigment epithelial cells, Surgery",
author = "Trevor McGill and David Wilson and Jonathan Stoddard and Renner, {Lauren M.} and Martha Neuringer",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-3-319-75402-4_78",
language = "English (US)",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "641--647",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Cell transplantation for retinal degeneration

T2 - Transition from rodent to nonhuman primate models

AU - McGill, Trevor

AU - Wilson, David

AU - Stoddard, Jonathan

AU - Renner, Lauren M.

AU - Neuringer, Martha

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Transplantation of potentially therapeutic cells into the subretinal space is a promising prospective therapy for the treatment of retinal degenerative diseases including age-related macular degeneration (AMD). In rodent models with photoreceptor degeneration, subretinal transplantation of cell suspensions has repeatedly been demonstrated to rescue behaviorally measured vision, maintain electrophysiological responses from the retina and the brain, and slow the degeneration of rod and cone photoreceptors for extended periods. These studies have led to the initiation of a number of FDA-approved clinical trials for application of cell-based therapy for AMD and other retinal degenerative diseases. However, translation from rodent models directly into human clinical trials skips an important intermediary preclinical step that is needed to address critical issues for intraocular cell transplantation. These include determination of the most appropriate and least problematic surgical approach, the application of treatment in an eye with similar size and structure including the presence of a macula, and a thorough understanding of the immunological considerations regarding graft survival and the consequences of grafted cell rejection. This chapter will review these and related issues and will document current efforts to address these concerns.

AB - Transplantation of potentially therapeutic cells into the subretinal space is a promising prospective therapy for the treatment of retinal degenerative diseases including age-related macular degeneration (AMD). In rodent models with photoreceptor degeneration, subretinal transplantation of cell suspensions has repeatedly been demonstrated to rescue behaviorally measured vision, maintain electrophysiological responses from the retina and the brain, and slow the degeneration of rod and cone photoreceptors for extended periods. These studies have led to the initiation of a number of FDA-approved clinical trials for application of cell-based therapy for AMD and other retinal degenerative diseases. However, translation from rodent models directly into human clinical trials skips an important intermediary preclinical step that is needed to address critical issues for intraocular cell transplantation. These include determination of the most appropriate and least problematic surgical approach, the application of treatment in an eye with similar size and structure including the presence of a macula, and a thorough understanding of the immunological considerations regarding graft survival and the consequences of grafted cell rejection. This chapter will review these and related issues and will document current efforts to address these concerns.

KW - Cell transplantation

KW - Immune rejection

KW - Nonhuman primate

KW - Retinal pigment epithelial cells

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=85046624540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046624540&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-75402-4_78

DO - 10.1007/978-3-319-75402-4_78

M3 - Chapter

C2 - 29721998

AN - SCOPUS:85046624540

T3 - Advances in Experimental Medicine and Biology

SP - 641

EP - 647

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -